Inflection of Akt/mTOR/STAT-3 cascade in TNF-α induced protein 8 mediated human lung carcinogenesis

Devivasha Bordoloi1, Kishore Banik1, Rajesh Vikkurthi1

  • 1Cancer Biology Laboratory, DBT-AIST International Center for Translational and Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam 781039, India.

Life Sciences
|September 25, 2020
PubMed

Insights

TNF-alpha induced protein 8 (TIPE) is upregulated in lung cancer, promoting tumor growth and metastasis. Targeting TIPE may offer new therapeutic strategies for lung cancer management.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Lung cancer remains a leading cause of cancer mortality globally.
  • Challenges in lung cancer management include late diagnosis, recurrence, and chemoresistance.
  • Effective biomarkers are crucial for improving lung cancer patient outcomes.

Purpose of the Study:

  • To investigate the role of TNF-alpha induced protein 8 (TIPE) as a potential biomarker and therapeutic target in lung cancer.
  • To elucidate the mechanisms by which TIPE contributes to lung cancer pathogenesis, including its involvement in tobacco-induced carcinogenesis.

Main Methods:

  • Analysis of TIPE expression in various lung cancer types, stages, and grades compared to normal lung tissue.
  • Assessment of the effects of TIPE knockout on lung cancer cell proliferation, survival, invasion, and migration.
  • Investigation of TIPE's signaling pathways, including Akt/mTOR/STAT-3.
  • Evaluation of TIPE's role in response to tobacco carcinogens (nicotine, NNK, NNN, BaP).

Main Results:

  • TIPE expression is significantly upregulated in lung tumors compared to normal lung tissue.
  • TIPE knockout reduces lung cancer cell proliferation, survival, invasion, and migration.
  • TIPE modulates the Akt/mTOR/STAT-3 signaling pathway.
  • TIPE promotes proliferation, survival, and migration in response to tobacco carcinogens, potentially via Akt/STAT-3 signaling.

Conclusions:

  • TIPE is an oncogenic molecule significantly involved in lung cancer development and progression.
  • TIPE plays a role in tobacco-induced lung carcinogenesis.
  • TIPE represents a promising therapeutic target for lung cancer treatment.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
9.8K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.0K